Sat Kartar
: SATKARTAR · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Sat Kartar's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sat Kartar Shopping Limited is an Ayurveda healthcare company that provides natural wellness solutions through therapeutic and lifestyle products. The company integrates traditional Ayurvedic principles with modern research to cater to health-conscious consumers.
Business Model
The company operates a Direct-to-Consumer (D2C) model, focusing on product innovation, branding, and marketing. It maintains an asset-light strategy by outsourcing its manufacturing requirements to third-party partners.
Growth Outlook
Growth is expected to be driven by the increasing consumer preference for natural and Ayurvedic wellness products. The company aims to leverage its D2C platform to expand its market reach and brand presence.
Key Risks
- Regulatory Compliance. The company is subject to stringent regulations governing Ayurvedic and healthcare products in India, which may impact product approvals and labelling.
- Supply Chain Dependency. Reliance on third-party manufacturers for production creates potential risks regarding quality control and supply chain disruptions.
- Market Competition. The D2C wellness sector is highly competitive, with numerous established players and new entrants vying for market share.
- Consumer Perception. The company's success is heavily dependent on maintaining consumer trust in the efficacy and safety of its Ayurvedic formulations.
Start your research today
Unlock AI insights, financials, peers and live data on Sat Kartar and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Sat KartarSATKARTAR | ₹220 Cr | — | — | — | 13.0% | — | — | -18.8% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Sat Kartar
: SATKARTAR · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Sat Kartar's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sat Kartar Shopping Limited is an Ayurveda healthcare company that provides natural wellness solutions through therapeutic and lifestyle products. The company integrates traditional Ayurvedic principles with modern research to cater to health-conscious consumers.
Business Model
The company operates a Direct-to-Consumer (D2C) model, focusing on product innovation, branding, and marketing. It maintains an asset-light strategy by outsourcing its manufacturing requirements to third-party partners.
Growth Outlook
Growth is expected to be driven by the increasing consumer preference for natural and Ayurvedic wellness products. The company aims to leverage its D2C platform to expand its market reach and brand presence.
Key Risks
- Regulatory Compliance. The company is subject to stringent regulations governing Ayurvedic and healthcare products in India, which may impact product approvals and labelling.
- Supply Chain Dependency. Reliance on third-party manufacturers for production creates potential risks regarding quality control and supply chain disruptions.
- Market Competition. The D2C wellness sector is highly competitive, with numerous established players and new entrants vying for market share.
- Consumer Perception. The company's success is heavily dependent on maintaining consumer trust in the efficacy and safety of its Ayurvedic formulations.
Start your research today
Unlock AI insights, financials, peers and live data on Sat Kartar and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026